Success Metrics

Clinical Success Rate
100.0%

Based on 37 completed trials

Completion Rate
100%(37/37)
Active Trials
8(15%)
Results Posted
3%(1 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

37 of 37 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

8

trials recruiting

Total Trials

55

all time

Status Distribution
Active(12)
Completed(37)
Other(6)

Detailed Status

Completed37
unknown6
Recruiting5
Not yet recruiting4
Active, not recruiting3

Development Timeline

Analytics

Development Status

Total Trials
55
Active
8
Success Rate
100.0%

Trials by Status

active_not_recruiting35%
not_yet_recruiting47%
unknown611%
recruiting59%
completed3767%

Recent Activity

Clinical Trials (55)

Showing 20 of 55 trialsScroll for more
NCT07687446

Performance of Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early Triple-Negative Breast Cancer

Not Yet Recruiting
NCT03515447

Romiplostim in Thoracic Transplantation

Completed
NCT02847052

Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease

Completed
NCT07658625

Association Between Oral Hypofunction, Sarcopenia and Social Frailty in Community-dwelling Older Adults

Completed
NCT07658612

Research on the Possible Relationship Between Sarcopenia and Oral Muscle Function

Completed
NCT06170671

REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania

Active Not Recruiting
NCT05437250

National Acalabrutinib Observational Study

Active Not Recruiting
NCT07602634

Radiomics Features Predicting Outcomes of PAD

Active Not Recruiting
NCT04590950

Dosage and PD Study of Eftrenonacog-alfa

Completed
NCT07291479

Behavioral Assessment Method Index

Recruiting
NCT06906380

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Not Yet Recruiting
NCT05213429

Middle East Coronary Artery Ectasia Registry

Recruiting
NCT06904547

Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCLC

Not Yet Recruiting
NCT06888180

Survey on NIV Settings in the Intensive Care Unit for Acute Exacerbation of COPD

Not Yet Recruiting
NCT06749015

A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)

Recruiting
NCT03350607

" Sweeper " and Epiretinal Membrane Surgery

Completed
NCT06328075

Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis

Recruiting
NCT03467529

Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study

Completed
NCT04807712

Pediatric Pertussis in Ambulatory Settings

Recruiting
NCT03345537

Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein

Completed

Drug Details

Intervention Type
OTHER
Total Trials
55